Compare MOD & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOD | MEDP |
|---|---|---|
| Founded | 1916 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 13.0B |
| IPO Year | 1995 | 2016 |
| Metric | MOD | MEDP |
|---|---|---|
| Price | $228.69 | $555.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | $223.71 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 1.3M | 291.9K |
| Earning Date | 05-19-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | 2.26 | ★ 4.28 |
| Revenue | ★ $1,352,500,000.00 | N/A |
| Revenue This Year | $23.05 | $13.19 |
| Revenue Next Year | $21.83 | $7.75 |
| P/E Ratio | ★ $102.30 | $130.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $86.48 | $306.70 |
| 52 Week High | $323.25 | $628.92 |
| Indicator | MOD | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 80.18 |
| Support Level | $230.61 | $551.00 |
| Resistance Level | $238.19 | $622.32 |
| Average True Range (ATR) | 16.39 | 18.16 |
| MACD | -5.98 | 8.09 |
| Stochastic Oscillator | 7.43 | 95.85 |
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.